U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
155761155761Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Panic Disorder With Comorbid Major DepressionCompletedHas ResultsPanic Disorder|Major Depressive DisorderDevice: Active Repetitive Transcranial Magnetic Stimulation (rTMS)|Device: Sham Repetitive Transcranial Magnetic Stimulation (rTMS)https://ClinicalTrials.gov/show/NCT00521352
155762155762Apremilast Safety and PK Study in Recalcitrant Plaque PsoriasisCompletedHas ResultsPlaque-Type PsoriasisDrug: Apremilasthttps://ClinicalTrials.gov/show/NCT00521339
155763155763Diagnosis and Characterization of Coronary Artery Stenosis by Doppler UltrasoundNot yet recruitingNo Results AvailableCoronary Stenosishttps://ClinicalTrials.gov/show/NCT00521326
155764155764Preoperative Octreotide Treatment of AcromegalyCompletedNo Results AvailableAcromegalyDrug: Octreotide|Procedure: Direct surgery for acromegalyhttps://ClinicalTrials.gov/show/NCT00521300
155765155765Impaired Immunity in Patients With Cancer: Influence of Cancer Stage, Chemotherapy, and Cytomegalovirus InfectionRecruitingNo Results AvailableNeoplasmsOther: Immune profiling and DC vaccinehttps://ClinicalTrials.gov/show/NCT00521287
155766155766Study of Trovax® Plus Docetaxel Versus Docetaxel Alone in Patients With Progressive Hormone Refractory Prostate CancerTerminatedNo Results AvailableProstatic NeoplasmsBiological: MVA 5T4|Drug: Docetaxelhttps://ClinicalTrials.gov/show/NCT00521274
155767155767Donor T Cells, Low-Dose Aldesleukin, and Low-Dose GM-CSF After Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaWithdrawnNo Results AvailableLymphomaBiological: anti-CD3 x anti-CD20 bispecific antibody-armed activated T cellshttps://ClinicalTrials.gov/show/NCT00521261
155768155768Buprenorphine for the Treatment of Neonatal Abstinence SyndromeCompletedNo Results AvailableNeonatal Abstinence SyndromeDrug: buprenorphine|Drug: Oral morphine solutionhttps://ClinicalTrials.gov/show/NCT00521248
155769155769Effect of Different Working Conditions on Risk Factors in Dentists Versus TrainersNot yet recruitingNo Results AvailableHealthyhttps://ClinicalTrials.gov/show/NCT00521235
155770155770Evaluating Long Acting Beta Agonists Used to Treat Asthma Among Those With Either Arg/Arg or Gly/Gly GenotypesActive, not recruitingNo Results AvailableAsthmaDrug: Fluticasone with salmeterol|Drug: Fluticasone HFAhttps://ClinicalTrials.gov/show/NCT00521222
155771155771Patient-Directed Lifestyle Change and Health Promotion Program or Usual Care in Low-Income, Uninsured Participants in Los Angeles County, CaliforniaRecruitingNo Results AvailableHealth Status UnknownBehavioral: exercise intervention|Dietary Supplement: dietary intervention|Other: counseling intervention|Other: medical chart review|Other: questionnaire administration|Procedure: complementary or alternative medicine procedurehttps://ClinicalTrials.gov/show/NCT00521209
155772155772Migraine--Investigational Treatment of Migraine With Noninvasive Brain Stimulation. (tDCS- Migraine)Active, not recruitingNo Results AvailableMigraineDevice: DC Stimulator (Transcranial Direct Current Stimulator)https://ClinicalTrials.gov/show/NCT00521196
155773155773Cytochlor, Tetrahydrouridine, and External-Beam Radiation Therapy in Treating Patients With Cancer That Has Spread to the BrainCompletedNo Results AvailableBrain and Central Nervous System TumorsDrug: Cytochlor|Drug: Tetrahydrouridine|Radiation: Radiation Therapyhttps://ClinicalTrials.gov/show/NCT00521183
155774155774Wheal and Flare Reaction During 24 Hours in Allergic Volunteers.CompletedNo Results AvailableAllergyDrug: Levocetirizinehttps://ClinicalTrials.gov/show/NCT00521170
155775155775Naltrexone Implants as an Aid in Preventing Relapse Following Inpatient Treatment for Opioid AddictionCompletedNo Results AvailableOpiate DependenceDrug: Go Medical Naltrexone implantshttps://ClinicalTrials.gov/show/NCT00521157
155776155776Obatoclax Mesylate and Topotecan Hydrochloride in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer or Advanced Solid TumorsCompletedHas ResultsRecurrent Small Cell Lung Cancer|Unspecified Adult Solid Tumor, Protocol SpecificDrug: obatoclax mesylate|Drug: topotecan hydrochloride|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00521144
155777155777Evaluation of Efficacy and Safety of Levocetirizine to Subjects With Perennial Allergic Rhinitis to House Dust MitesCompletedNo Results AvailableRhinitis|Allergic|PerennialDrug: Levocetirizine dihydrochloridehttps://ClinicalTrials.gov/show/NCT00521131
155778155778Second Curettage in Treating Patients With Persistent Non-Metastatic Gestational Trophoblastic TumorRecruitingNo Results AvailableGestational Trophoblastic TumorOther: laboratory biomarker analysis|Procedure: conventional surgeryhttps://ClinicalTrials.gov/show/NCT00521118
155779155779Assessment of an Alternative Model of Follow-up of Children and Adolescents With Type 1 DiabetesCompletedNo Results AvailableType 1 Diabetes MellitusOther: Virtual visithttps://ClinicalTrials.gov/show/NCT00521105
155780155780Sunitinib Malate in Treating East African Patients With Kaposi SarcomaWithdrawnNo Results AvailableAIDS-related Kaposi Sarcoma|Classic Kaposi SarcomaDrug: sunitinib malate|Procedure: laboratory biomarker analysis|Procedure: pharmacological studyhttps://ClinicalTrials.gov/show/NCT00521092
155781155781EMPOWER Clinical Trial: Vagal Blocking for Obesity ControlActive, not recruitingNo Results AvailableObesityDevice: Active, implantable, intra-abdominal vagal blocking medical devicehttps://ClinicalTrials.gov/show/NCT00521079
155782155782GYNECARE PROSIMA* Pelvic Floor Repair System for Pelvic Organ ProlapseCompletedNo Results AvailablePelvic Organ ProlapseDevice: GYNECARE PROSIMA* Pelvic Floor Repair Systemhttps://ClinicalTrials.gov/show/NCT00521066
155783155783Phase 2 Study of Intralesional PV-10 for Metastatic MelanomaCompletedHas ResultsMelanomaDrug: PV-10 (10% rose bengal disodium)https://ClinicalTrials.gov/show/NCT00521053
155784155784Efficacy and Safety of Levocetirizine 8 Weeks Prior and After the Onset of the Grass Pollen Season in Subjects With SARCompletedNo Results AvailableRhinitis, Allergic, SeasonalDrug: Levocetirizine dihydrochloridehttps://ClinicalTrials.gov/show/NCT00521040
155785155785Study Comparing VERSAJET With Conventional Surgical Procedures in the Removal of Unhealthy Tissue From Lower Limb UlcersCompletedNo Results AvailableDiabetic Foot|Varicose Ulcer|Pressure UlcerDevice: Versajet Hydrosurgery System|Procedure: Conventional surgical debridement techniqueshttps://ClinicalTrials.gov/show/NCT00521027
155786155786GM-CSF and Rituximab After Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Follicular Non-Hodgkin LymphomaCompletedNo Results AvailableLymphomaBiological: filgrastim|Biological: rituximab|Biological: sargramostim|Drug: carmustine|Drug: cytarabine|Drug: etoposide|Drug: melphalan|Procedure: autologous hematopoietic stem cell transplantationhttps://ClinicalTrials.gov/show/NCT00521014
155787155787Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by SurgeryCompletedNo Results AvailableMelanoma (Skin)Drug: everolimus|Drug: temozolomidehttps://ClinicalTrials.gov/show/NCT00521001
155788155788Improving Blood Pressure in ColoradoCompletedNo Results AvailableHypertensionBehavioral: Use of telephone-based Interactive Voice Recognition systemhttps://ClinicalTrials.gov/show/NCT00520988
155789155789First-Line Chemotherapy and Trastuzumab With or Without Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEUActive, not recruitingNo Results AvailableHER2/Neu Positive|Male Breast Carcinoma|Recurrent Breast Carcinoma|Stage IV Breast CancerBiological: Bevacizumab|Drug: Carboplatin|Other: Laboratory Biomarker Analysis|Drug: Paclitaxel|Other: Placebo|Other: Quality-of-Life Assessment|Biological: Trastuzumabhttps://ClinicalTrials.gov/show/NCT00520975
155790155790Screening for Undiagnosed Type 2 Diabetes in New Classes of Subjects at High RiskCompletedNo Results AvailableDiabetes Mellitus, Type 2https://ClinicalTrials.gov/show/NCT00520962

* Görseller ve İçerik tekif hakkına sahip olabilir